Mercalis in Motion

On this episode of Mercalis in Motion, Sean Boyler, Tom Gottschalk, and Robbie Hill join us in the studio to commemorate the 15-year anniversary of RxStudy Card.  What follows is a conversation about how RxStudy Card by Mercalis has evolved over the years to save our clients millions of dollars in time and money while eliminating waste associated with the traditional clinical trial supply process.

Today, Landy and Eric welcome three members of the Mercalis Products Team to the studio.  Bill Dupere, Stephanie Chesebro, and Nick Hill stopped by to discuss recent developments related to the Mercalis eServices and Curator capabilities.  In November 2023, Mercalis announced an exclusive perpetual license to a portfolio of access and adherence technologies from OptimizeRx. Since then, the Products Team has been busy integrating and enhancing its catalog of market-leading patient support services offerings.

In this episode, Heather Smith, PhD, RN, NNP visits the studio to discuss the Mercalis Nurse Network.  For the past seven years, Mercalis has provided its clients and their patients with a growing suite of services focused on patient care and education.  The need for our Nurse Network was realized when we observed that parents and caregivers were being asked to mix medications and inject their children or family members.  Since then, Mercalis nurses have served as an important link in the education of caregivers, leading to better adherence and superior outcomes for countless patients.

In this episode, Landy and Eric sit down with Jason Zemcik, Andrea Xu, and Bethany Najer of Policy Reporter by Mercalis to dive into a number of issues that are facing the life sciences market, as well as an update on Policy Reporter's offerings and what's on the horizon for the growing healthcare information management company . Tune in for a thought-provoking conversation about market dynamics and advancements in market access.

Today on Mercalis in Motion, we’re pleased to share an episode featuring our colleagues from Triangle Insights Group by Mercalis. Triangle Insights Group, acquired by Mercalis in April 2022, is a premier strategy consulting firm providing guidance on critical business issues to life science industry leaders.  On this episode, Matt Haynes and Meghna Shankar discuss a recent white paper titled “The Indirect Impacts of the Inflation Reduction Act on Pharmaceutical Pipeline and Portfolio Strategy”, co-authored by Shankar and Triangle Principal Megan Thomas.

Rare Disease Day is an observance that takes place worldwide to raise awareness for rare diseases and improve access to treatment and medical representation for individuals with rare diseases and their families.  Rare Disease Day typically takes place on or near the last day of February.  In this episode of Mercalis in Motion, Landy and Eric welcome to the studio two guests from Catalyst Pharmaceuticals — Amy Grover, Senior Director of Patient Advocacy and Carrie Ostrea, Senior Manager of Patient Advocacy.  We are also joined by our Mercalis colleague John Katter, who serves as a Director, Business Development.  Please join us as Amy, Carrie, and John discuss the importance of acknowledging the rare disease community and highlight the work that Catalyst and Mercalis have done for this very important patient population.

Mercalis CEO Scott Dulitz joins Landy and Eric for Mercalis in Motion’s first podcast episode of 2024.  Scott reflects on a very eventful and successful 2023 as well as what lies ahead for the life sciences commercialization partner in 2024 and beyond. 

In this episode, our hosts Landy Townsend, Vice President of Marketing and Communications, and Eric Manning, Creative Director, take a look back at 2023, highlighting notable guests and key discussions from the past 12 months. No frills or fluff—just a recap of some of the people and topics that made an impact. Whether you're a regular listener or just tuning in, join us for a review of the conversations that shaped our year. 

Copay accumulators have been a major topic of discussion in the life sciences community for the past several years, and Mercalis has been extremely busy providing continued guidance and support to our clients who have been impacted. After several recent legal developments, we decided to devote an episode of our Mercalis in Motion podcast to discuss the latest updates via a roundtable discussion. We welcomed to the studio our colleague Michael Harris, Mercalis’ VP of Patient Support Services Strategy. He was joined by Carl Schmid, the Executive Director at the HIV + Hepatitis Policy Institute and Bill Sarraille, a Partner with the Sidley law firm in Washington, D.C. This information will be very helpful to life sciences decision makers who are planning for 2024 and beyond.

In this episode of Mercalis in Motion, we welcome to the studio Mercalis CEO Scott Dulitz to discuss TrialCard’s recent rebranding initiative that resulted in the creation of Mercalis.  Scott discusses the reasons that led to the rebranding, how we arrived at the name Mercalis, and what’s next for the growing integrated life sciences commercialization partner.